B cells promote granulomatous inflammation during chronic Mycobacterium tuberculosis infection in mice

The current study reveals that in chronic TB, the B cell-deficient μMT strain, relative to wild-type (WT) C57BL/6 mice, displays in the lungs lower levels of inflammation that are associated with decreased CD4+ T cell proliferation, diminished Th1 response, and enhanced levels of interleukin (IL)-10. The latter result raises the possibility that B cells may restrict lung expression of IL-10 in chronic TB. These observations are recapitulated in WT mice depleted for B cells using anti-CD20 antibodies. IL-10 receptor (IL-10R) blockade reverses the phenotypes of decreased inflammation and attenuated CD4+ T cell responses in B cell-depleted mice. Together, these results suggest that in chronic murine TB, B cells, by virtue of their capacity to restrict expression of the anti-inflammatory and immunosuppressive IL-10 in the lungs, promote the development of a robust protective Th1 response, thereby optimizing anti-TB immunity. This vigorous Th1 immunity and restricted IL-10 expression may, however, allow the development of inflammation to a level that can be detrimental to the host. Indeed, decreased lung inflammation observed in chronically infected B cell-deficient mice, which exhibit augmented lung IL-10 levels, is associated with a survival advantage relative to WT animals. Collectively, the results reveal that in chronic murine TB, B cells play a role in modulating the protective Th1 immunity and the anti-inflammatory IL-10 response, which results in augmentation of lung inflammation that can be host-detrimental. Intriguingly, in tuberculous human lungs, conspicuous B cell aggregates are present in close proximity to tissue-damaging lesions manifesting necrosis and cavitation, suggesting the possibility that in human TB, B cells may contribute to the development of exacerbated pathology that is known to promote transmission. Since transmission is a major hindrance to TB control, investigating into whether B cells can shape the development of severe pulmonic pathological responses in tuberculous individuals is warranted.

[1]  D. Sherman,et al.  Early alveolar macrophage response and IL-1R-dependent T cell priming determine transmissibility of Mycobacterium tuberculosis strains , 2022, Nature Communications.

[2]  M. van de Rijn,et al.  The immunoregulatory landscape of human tuberculosis granulomas , 2022, Nature Immunology.

[3]  S. P. Parihar,et al.  IL-4-Responsive B Cells Are Detrimental During Chronic Tuberculosis Infection in Mice , 2021, Frontiers in Immunology.

[4]  R. Hunter,et al.  µCT Analysis of the Human Tuberculous Lung Reveals Remarkable Heterogeneity in 3D Granuloma Morphology. , 2021, American journal of respiratory and critical care medicine.

[5]  W. Bishai,et al.  Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis , 2021, Frontiers in Immunology.

[6]  W. Bishai,et al.  The integrated stress response mediates necrosis in murine Mycobacterium tuberculosis granulomas. , 2020, The Journal of clinical investigation.

[7]  D. Alland,et al.  Transmission phenotype of Mycobacterium tuberculosis strains is mechanistically linked to induction of distinct pulmonary pathology , 2019, PLoS pathogens.

[8]  G. Altan-Bonnet,et al.  Cytokine-mediated communication: a quantitative appraisal of immune complexity , 2019, Nature Reviews Immunology.

[9]  Chih-Chung Lin,et al.  Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection , 2018, The Journal of experimental medicine.

[10]  S. Fortune,et al.  Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection , 2018, Nature Reviews Immunology.

[11]  A. Sher,et al.  Type I interferons in tuberculosis: Foe and occasionally friend , 2018, The Journal of experimental medicine.

[12]  D. Weissman,et al.  Tuberculosis and lung damage: from epidemiology to pathophysiology , 2018, European Respiratory Review.

[13]  L. Jouneau,et al.  B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis , 2017, American journal of respiratory and critical care medicine.

[14]  S. Fortune,et al.  Heterogeneity in tuberculosis , 2017, Nature Reviews Immunology.

[15]  D. Barber,et al.  Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis. , 2017, Cell reports.

[16]  W. Jacobs,et al.  CD4+ T-cell–independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection , 2016, Proceedings of the National Academy of Sciences.

[17]  A. Sharpe,et al.  CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease , 2016, PLoS pathogens.

[18]  Ping Shen,et al.  Antibody-independent functions of B cells: a focus on cytokines , 2015, Nature Reviews Immunology.

[19]  P. Roche,et al.  Suppression of antigen presentation by IL-10. , 2015, Current opinion in immunology.

[20]  P. Fink,et al.  ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis , 2015, The Journal of experimental medicine.

[21]  A. Azad,et al.  Characterization of Host and Microbial Determinants in Individuals with Latent Tuberculosis Infection Using a Human Granuloma Model , 2015, mBio.

[22]  A. Sher,et al.  Type I interferons in infectious disease , 2015, Nature Reviews Immunology.

[23]  Xuetao Cao,et al.  The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review. , 2014, Journal of autoimmunity.

[24]  A. Casadevall,et al.  The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. , 2014, Seminars in immunology.

[25]  Simon A. Jones,et al.  Ectopic lymphoid-like structures in infection, cancer and autoimmunity , 2014, Nature Reviews Immunology.

[26]  D. Barber,et al.  Cutting Edge: Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma–Homing CD4 T Cells , 2014, The Journal of Immunology.

[27]  R. Sobel,et al.  MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies , 2013, The Journal of experimental medicine.

[28]  B. Bloom,et al.  TB or Not TB: That Is No Longer the Question , 2013, Science Translational Medicine.

[29]  J. Flynn,et al.  B Cells Regulate Neutrophilia during Mycobacterium tuberculosis Infection and BCG Vaccination by Modulating the Interleukin-17 Response , 2013, PLoS pathogens.

[30]  L. Ramakrishnan,et al.  TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species , 2013, Cell.

[31]  F. Lund,et al.  IL-17-producing B cells combat parasites , 2013, Nature Immunology.

[32]  Robert J Wilkinson,et al.  The immune response in tuberculosis. , 2013, Annual review of immunology.

[33]  D. Liggitt,et al.  Trypanosoma cruzi trans-sialidase initiates an ROR-γt–AHR-independent program leading to IL-17 production by activated B cells , 2013, Nature immunology.

[34]  G. Beamer,et al.  IL-10 Inhibits Mature Fibrotic Granuloma Formation during Mycobacterium tuberculosis Infection , 2013, The Journal of Immunology.

[35]  M. Selman,et al.  CXCR5⁺ T helper cells mediate protective immunity against tuberculosis. , 2013, The Journal of clinical investigation.

[36]  Ravi S. Misra,et al.  Unraveling effector functions of B cells during infection: the hidden world beyond antibody production. , 2012, Infectious disorders drug targets.

[37]  John P. Ray,et al.  Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections , 2012, Cell.

[38]  R. Hunter Pathology of post primary tuberculosis of the lung: an illustrated critical review. , 2011, Tuberculosis.

[39]  A. Azad,et al.  Comparative Transcriptional Study of the Putative Mannose Donor Biosynthesis Genes in Virulent Mycobacterium tuberculosis and Attenuated Mycobacterium bovis BCG Strains , 2011, Infection and Immunity.

[40]  N. Fujiwara,et al.  Human Lung Hydrolases Delineate Mycobacterium tuberculosis–Macrophage Interactions and the Capacity To Control Infection , 2011, The Journal of Immunology.

[41]  J. Ernst,et al.  Initiation and regulation of T-cell responses in tuberculosis , 2011, Mucosal Immunology.

[42]  A. O’Garra,et al.  The role of IL-10 in immune regulation during M. tuberculosis infection , 2011, Mucosal Immunology.

[43]  S. Rutz,et al.  Regulation and functions of the IL-10 family of cytokines in inflammation and disease. , 2011, Annual review of immunology.

[44]  G. Bancroft,et al.  Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung , 2010, European journal of immunology.

[45]  T. Randall,et al.  Effector and regulatory B cells: modulators of CD4+ T cell immunity , 2010, Nature Reviews Immunology.

[46]  T. Randall,et al.  In a Murine Tuberculosis Model, the Absence of Homeostatic Chemokines Delays Granuloma Formation and Protective Immunity1 , 2009, The Journal of Immunology.

[47]  Amit Singh,et al.  Mycobacterium tuberculosis WhiB3 Maintains Redox Homeostasis by Regulating Virulence Lipid Anabolism to Modulate Macrophage Response , 2009, PLoS pathogens.

[48]  D. Flaherty,et al.  Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice1 , 2008, The Journal of Immunology.

[49]  C. Hawrylowicz,et al.  Strategies for use of IL‐10 or its antagonists in human disease , 2008, Immunological reviews.

[50]  F. Lund Cytokine-producing B lymphocytes-key regulators of immunity. , 2008, Current opinion in immunology.

[51]  J. Mainardi,et al.  The Peptidoglycan of Stationary-Phase Mycobacterium tuberculosis Predominantly Contains Cross-Links Generated by l,d-Transpeptidation , 2008, Journal of bacteriology.

[52]  M. Palmer,et al.  Associations between cytokine gene expression and pathology in Mycobacterium bovis infected cattle. , 2007, Veterinary immunology and immunopathology.

[53]  T. Laskay,et al.  Interferon‐gamma‐dependent mechanisms of mycobacteria‐induced pulmonary immunopathology: the role of angiostasis and CXCR3‐targeted chemokines for granuloma necrosis , 2007, The Journal of pathology.

[54]  J. Chan,et al.  B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis1 , 2007, The Journal of Immunology.

[55]  P. Guermonprez,et al.  Antigen presentation by B lymphocytes: how receptor signaling directs membrane trafficking. , 2007, Current opinion in immunology.

[56]  W. Britton,et al.  Life and death in the granuloma: immunopathology of tuberculosis , 2007, Immunology and cell biology.

[57]  D. Bruder,et al.  Cellular immunity and lung injury in respiratory virus infection. , 2006, Viral immunology.

[58]  Smita Y. Patel,et al.  Host genetic factors and mycobacterial infections: lessons from single gene disorders affecting innate and adaptive immunity. , 2006, Microbes and infection.

[59]  F. Aloisi,et al.  Lymphoid neogenesis in chronic inflammatory diseases , 2006, Nature Reviews Immunology.

[60]  J. Flynn,et al.  Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension , 2006, Cellular microbiology.

[61]  Daniel Rodríguez‐Pinto B cells as antigen presenting cells. , 2005, Cellular immunology.

[62]  A. Levine,et al.  Eradication of Helicobacter pylori and Resolution of Gastritis in the Gastric Mucosa of IL‐10‐Deficient Mice , 2005, Helicobacter.

[63]  H. C. van der Heyde,et al.  Plasmodium chabaudi adami: use of the B-cell-deficient mouse to define possible mechanisms modulating parasitemia of chronic malaria. , 2005, Experimental parasitology.

[64]  Alimuddin Zumla,et al.  Lung remodeling in pulmonary tuberculosis. , 2005, The Journal of infectious diseases.

[65]  S. Kaveri,et al.  Modulation of Dendritic Cell Maturation and Function by B Lymphocytes1 , 2005, The Journal of Immunology.

[66]  I. Orme,et al.  Interleukin‐10 production by lung macrophages in CBA xid mutant mice infected with Mycobacterium tuberculosis , 2005, Immunology.

[67]  T. Randall,et al.  Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. , 2005, Current directions in autoimmunity.

[68]  S. Kaufmann,et al.  Human tuberculous granulomas induce peripheral lymphoid follicle‐like structures to orchestrate local host defence in the lung , 2004, The Journal of pathology.

[69]  T. van der Poll,et al.  IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection , 2004, The Journal of Immunology.

[70]  Rainer Döffinger,et al.  Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[71]  J. Flynn,et al.  Immunology of tuberculosis. , 2003, Annual review of immunology.

[72]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[73]  S. Swain,et al.  Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.

[74]  K. Elkins,et al.  Infection of B Cell-Deficient Mice with CDC 1551, a Clinical Isolate of Mycobacterium tuberculosis: Delay in Dissemination and Development of Lung Pathology1 , 2000, The Journal of Immunology.

[75]  Ching Li,et al.  A Defect in Interleukin-10 Leads to Enhanced Malarial Disease in Plasmodium chabaudi chabaudi Infection in Mice , 1999, Infection and Immunity.

[76]  J. Flynn,et al.  Reactivation of Latent Tuberculosis: Variations on the Cornell Murine Model , 1999, Infection and Immunity.

[77]  P. Haslett,et al.  Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. , 1999, Journal of immunology.

[78]  S. Dorman,et al.  A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection , 1999, Nature Genetics.

[79]  J. Casanova,et al.  Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. , 1997, The Journal of clinical investigation.

[80]  M. Newport,et al.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. , 1996, The New England journal of medicine.

[81]  A. Sher,et al.  In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. , 1996, Journal of immunology.

[82]  G. Rook,et al.  Pathogenesis of Pulmonary Tuberculosis: an Interplay of Tissue-Damaging and Macrophage-Activating Immune Responses—Dual Mechanisms That Control Bacillary Multiplication , 1994 .

[83]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[84]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[85]  M. Farrar,et al.  The molecular cell biology of interferon-gamma and its receptor. , 1993, Annual review of immunology.

[86]  Klaus Rajewsky,et al.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.

[87]  HighWire Press European respiratory review : an official journal of the European Respiratory Society. , 1991 .

[88]  A. Lanzavecchia,et al.  Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. , 1990, Annual review of immunology.